GENE ONLINE|News &
GeneOnline’s Top Mergers and Acquisitions of 2019
2019 was a year replete with major pharma, biotech, and digital healthcare deals. Here we highlight some of the major mergers and acquisitions of the year.
The year 2019 began with the big news of Bristol-Myers Squibb (BMS) agreeing to acquire Celgene Corporation for a value of about US$ 74 billion.According to data compiled by Refinitiv,
The year 2019 began with the big news of Bristol-Myers Squibb (BMS) agreeing to acquire Celgene Corporation for a value of about US$ 74 billion.According to data compiled by Refinitiv,
GO Prime with only $1.49 now
LATEST
AACR Annual Meeting 2025: Cancer Research Innovations, NIH Funding Advocacy, and AI-Driven Advances
2025-04-28
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
